ClinicalTrials.gov research-record snapshot for Orlando, FL
Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 21 results; after an exact city/state check of listed facilities, 18 records were retained for Orlando, Florida. It is not a clinic, enrollment, or local-availability directory.
Snapshot methodology and exact-location matching
City/state source filter
Orlando, Florida
Exact-location inclusion rule
A listed facility city and state must match Orlando, Florida.
Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.
Fixed query terms
semaglutide
tirzepatide
cagrilintide
retatrutide
tesamorelin
sermorelin
ipamorelin
bpc-157
thymosin alpha 1
pt-141
Included study statuses
RECRUITING
NOT_YET_RECRUITING
ACTIVE_NOT_RECRUITING
ENROLLING_BY_INVITATION
How to read this snapshot
Research-record limits
This is not a clinic, enrollment, local-service, or local-availability directory.
Why Peptides does not recommend sites, assess eligibility, or provide medical advice.
A listing or study-level status does not prove enrollment, eligibility, safety, effectiveness, or availability.
Each displayed registry status is a study-level overall status, not a facility enrollment status.
Links on this page lead only to the cited ClinicalTrials.gov source records and search pages.
Records are a fixed snapshot, not a complete or live catalog.
All retained records
Study-level status mix
The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.
RECRUITING
5 records
NOT_YET_RECRUITING
1 record
ACTIVE_NOT_RECRUITING
12 records
ENROLLING_BY_INVITATION
0 records
Records in this snapshot
Retained ClinicalTrials.gov NCT records
The retrieved source snapshot contains 18 exact-location records and 17 listed facilities. All 18 retained records are shown below.
Registry title: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Charter Research - Winter ParkOrlando, Florida 32803
Registry title: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Orlando HealthOrlando, Florida 32806
Digestive and Liver Center of FloridaOrlando, Florida 32825
Registry title: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Orlando HealthOrlando, Florida 32806
Digestive and Liver Center of FloridaOrlando, Florida 32825
Registry title: A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Study-level overall status
NOT_YET_RECRUITING
Record update date
Exact-matched listed facility/location
Florida Inst For Clin Res LLCOrlando, Florida 32825
Registry title: STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
Registry title: Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
Advent HealthOrlando, Florida 32804
K2 Medical Research South OrlandoOrlando, Florida 32806
Orlando Health Weight Loss and Bariatric Surgery InstituteOrlando, Florida 32806
Registry title: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
Charter Research - Winter ParkOrlando, Florida 32803
Source retrieval and snapshot limits
Source-query results versus exact-location records
At retrieval, the fixed ClinicalTrials.gov source query returned 21 results. After an exact city/state check of listed facilities, 18 records were retained for Orlando, Florida, across 17 listed facilities. All 18 retained records are shown on this page.
Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.
Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.